News

Investigators from NCI’s Center for Cancer Research developed a software package to perform high-throughput analysis of extracellular vesicles, which are particles a cell releases that can promote cell growth and survival. NCI is now seeking research co-development partners and/or licensees for this biomarker analysis software.

If you’re attending the 2022 American Association for Cancer Research Annual Meeting (either in person or virtual), don’t miss these data science sessions, poster presentations, and the NCI exhibit booth, where you can hear more about our programs and activities!

Do you work on a project funded by an active NIH grant? Is this project rooted in artificial intelligence, machine learning, and/or ethics components? Apply to this Notice of Special Interest by March 31, 2022.

Over the past several years, scientists have made exciting advances in the realm of artificial intelligence (AI) and its integration into the cancer imaging field. New AI tools could make cancer imaging faster, more accurate, and more informative. But are they ready for real-world implementation?

NCI has just launched the Molecular Characterization Initiative, fostering data sharing in childhood cancer research. This program offers tumor molecular characterization to children, adolescents, and young adults who have been diagnosed with central nervous system tumors and are being treated at hospitals affiliated with an NCI-supported clinical trials group, “Children’s Oncology Group.” The DNA and RNA in participants' tumors are analyzed through this voluntary, free program. Once data is available, cancer researchers will be able to access the data via the Cancer Research Data Commons.

Looking for canine urothelial carcinoma data? RNA sequencing and clinical data from a phase I/II trial, listed in the EACR’s top 10 publications, is available for analysis through NCI’s Integrated Canine Data Commons.

Have experience with data management, high performance computing, and/or machine learning/artificial intelligence? Are you a proven IT manager and leader? Become a Staff Scientist/Facility Head to direct and manage a shared Scientific Computing and Informatics Core within the National Institute on Drug Abuse, a sister institute of the National Cancer Institute.

CBIIT Director, Dr. Tony Kerlavage, sat down recently for a podcast examining the evolution of NCI’s Data Commons. He tracked the development of the Cancer Research Data Commons, from its early pilots to today’s cloud-based infrastructure, with repositories of diverse data and more than 1,000 tools and resources.

Check out the latest quarterly updates made to terminologies and ontologies developed and maintained by NCI’s Enterprise Vocabulary Services (EVS) including the NCI Thesaurus and the Clinical Data Interchange Standards Consortium’s (CDISC’s) controlled terminology. EVS content developed in collaboration with CDISC, FDA, NCI programs, and other stakeholders is an indispensable component of NCI’s informatics infrastructure. EVS not only plays a critical role in federal and global data standards but also provides services to accurately code, analyze, and share cancer and biomedical research.

NCI has reissued a Funding Opportunity Announcement soliciting applications for a Data, Evaluation, and Coordinating Center (DECC) for the Connecting Underrepresented Populations to Clinical Trials program (CUSP2CT). Letters of Intent are due February 26, 2022, and applications are due March 28, 2022.